Daehan New Pharm Co. Ltd (054670) — Cash Flow Quality Index
Daehan New Pharm Co. Ltd (054670) has a Cash Flow Quality Index of 1.70x as of September 2025. Operating cash flow of ₩4.43 Billion exceeds net income of ₩2.61 Billion, indicating high earnings quality where cash backs reported profits. Explore cash efficiency ratio of Daehan New Pharm Co. Ltd to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Daehan New Pharm Co. Ltd Cash Flow Quality Index (2009–2024)
Historical Cash Flow Quality Index for Daehan New Pharm Co. Ltd across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how aggressively does Daehan New Pharm Co. Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Daehan New Pharm Co. Ltd (2009–2024)
Year-by-year earnings quality comparison for Daehan New Pharm Co. Ltd. For live market cap and the full company financial profile, see market value of Daehan New Pharm Co. Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.22x | ₩18.95 Billion | ₩15.47 Billion | ▲ +22.2% |
| 2023 | 1.00x | ₩12.57 Billion | ₩12.54 Billion | ▲ +70.9% |
| 2022 | 0.59x | ₩14.25 Billion | ₩24.32 Billion | ▼ -44.5% |
| 2021 | 1.06x | ₩16.58 Billion | ₩15.69 Billion | ▼ -29.7% |
| 2019 | 1.50x | ₩22.89 Billion | ₩15.24 Billion | ▼ -82.0% |
| 2018 | 8.34x | ₩20.47 Billion | ₩2.45 Billion | ▲ +343.3% |
| 2015 | 1.88x | ₩7.80 Billion | ₩4.15 Billion | ▼ -50.0% |
| 2014 | 3.76x | ₩10.02 Billion | ₩2.66 Billion | ▼ -29.1% |
| 2011 | 5.31x | ₩3.42 Billion | ₩643.55 Million | ▲ +183.2% |
| 2009 | -6.38x | ₩-2.30 Billion | ₩360.71 Million | — |